Navigation Links
Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance
Date:2/27/2009

NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has signed a Memorandum of Understanding (MOU) confirming its interest in exploring the development of a strategic alliance with Beijing Pharmaceutical Group Co. Ltd. (BPGC). The MOU confirms the intention of BPGC to consider a range of collaborative global business development opportunities with Immtech.

BPGC is one of the largest state-owned pharmaceutical and medical device conglomerates in China. BPGC develops, manufactures, and sells Chinese and western medicines, bio-medicines, health products, pharmaceutical raw materials, medical equipment, and medicine manufacturing equipment. BPGC had annual sales of over USD $2 billion in 2008.

The strategic alliance would give BPGC rights to develop drugs from Immtech's extensive proprietary library of compounds. Many of these compounds have been designed to target high-prevalence diseases such as hepatitis C and malaria, which are devastating infectious diseases that result in millions of deaths each year around the world. The strategic alliance would also allow BPGC to leverage Immtech's extensive network of international relationships to gain access to patented technologies as well as advantageous sales and distribution channels in the US, the Middle East, Africa, Europe, and other locations.

"We are excited about the possibility of entering into this strategic alliance. BPGC has substantial resources and an excellent track record. They are an ideal partner to draw on Immtech's extensive portfolio of compounds as well as our strong international network of collaborators in drug development and other business areas," said Eric L. Sorkin, Chairman and CEO of Immtech.

Pending BPGC's satisfactory review and valuation of Immtech assets, the companies will continue negotiations related to details of the strategic
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Immtech Announces Appointment of Virchow Krause as Independent Registered Public Accounting Firm
2. Immtech Reports Fiscal First Quarter 2009 Results
3. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
4. Immtech Appoints Blythe Weigh as Strategic Advisor
5. Immtech Reports Fiscal Third Quarter 2008 Results
6. Immtech Investor Conference Call Scheduled for February 11, 2008
7. Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine
8. Immtech to Present at The Bank of Montreal Healthcare Conference
9. China Biologic Products to Present at the SIG Beijing Management Summit
10. China Bio Energy Holdings Group Announces Participation in the Susquehanna Second Annual Beijing Management Summit
11. Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013  Continuing its long history of proven ... Beckman Coulter , Inc. announces the U.S. Food and ... AccuTnI+3 troponin I assay for use on its Access ... on Beckman Coulter,s troponin I test for ... the proven performance to continue providing dependability to laboratories ...
(Date:6/19/2013)... India , June 19, ... Bharat Book Bureau presents Innovative ... and Formulation Technology Licensing Opportunities ... http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html ) There ... or controlled release drugs approved ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of DrugCheck® ... has received Class III medical device license approval from ... NxStep Onsite Drug Screen Cup in Canada. Class ... in near-patient settings, such as physicians’ offices. , The ... Class III approval for 24 different drugs and detection ...
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... innovation and sustainability, the Consulate General of Switzerland in ... solar boat, Switzerland’s MS Tûranor PlanetSolar , to ... part of its DeepWater Expedition 2013 tour with scientists ... led by Capitain Gérard d’Aboville, runs exclusively on energy ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4
... NEW YORK, Dec. 29, 2010 Reportlinker.com ... is available in its catalogue: Molecular ... The technologies that ... fluorescent in situ hybridization (FISH), second-generation biochips ...
... 2010   Today, Gov. Bobby Jindal joined Myriant ... Port of Lake Providence Director Wyly Gilfoil to ... Lake Providence Inc., will soon begin building a ... Providence that will be the world,s largest bio-based ...
... 2010 Market Publishers Ltd informs that new in-demand ... to its catalogue " Drugs & Biotechnology ." ... regularly updated, professional patent search which not only identifies ... by a convenient online interface. ...
Cached Biology Technology:Reportlinker Adds Molecular Diagnostics Markets 2Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence 2Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence 3New Topical Patent Research Reports Recently Published at MarketPublishers.com 2New Topical Patent Research Reports Recently Published at MarketPublishers.com 3
(Date:6/18/2013)... of Medicine have discovered a mechanism that is used ... component of blood typically associated with clotting, were discovered ... seal it off from the rest of the body. ... this week, provide the science community with a ... known that platelets do participate in immunity, but now ...
(Date:6/18/2013)... large "dead zone" in the Gulf of Mexico and ... Bay this year, based on several NOAA-supported forecast models. ... State University, and the Louisiana Universities Marine Consortium ... "dead" zone will be between 7,286 and 8,561 square ... recorded. That would range from an area the size ...
(Date:6/18/2013)... Association for Molecular Pathology is proud to announce it ... Biology (FASEB) on July 1, 2013. The FASEB Board ... , The 26 constituent societies of FASEB represent ... for the advancement of research and education in biological ... more important now than ever," said Jennifer L. Hunt, ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4
... impair the ability of ecosystems to perform vital ... sequestrationsays the nation,s largest organization of ecological scientists. ... of America (ESA) outlines strategies that focus on ... and adapt to climate change. "Decision-makers cannot ...
... wisdom, a new study from plant biologists at UC Davis ... proteins across the membranes of chloroplasts, just as they do ... in the January issue of the journal The Plant ... a living cell is to move things across membranes, both ...
... periods do not indicate long-term trends. An assessment of hundreds ... phenomenon today is in fact nothing new," explains Dr. Dorit ... in Israel has been rising and falling over the past ... lowest levels, most of the time below the present-day level. ...
Cached Biology News:Managing ecosystems in a changing climate 2Managing ecosystems in a changing climate 3Green plant transport mystery solved 2The sea level has been rising and falling over the last 2,500 years 2
... The Label IT siRNA Tracker ... Reagent provides a straight forward approach ... of your design, in an efficient ... tracking experiments. Subcellular localization and functional ...
... siRNA Tracker Intracellular Localization Kit with ... forward approach to directly label and ... an efficient yet non-destructive manner, for ... and functional inhibition of target gene ...
... Gasket slide kit (1x 22K gasket/slide) G2534-60003 ... or Gasket slide kit (2x 11K ... slides offered in either 11K or 22K microarray feature ... gaskets are carefully fabricated and batch tested to ensure ...
... self locking design in ice/water bath ... product number, created to easily match ... availability yet, please order under the ... customer service for assistance. ID clarifier: ...
Biology Products: